Gene · 406987
Papers4,222
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,222
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatics analysis and experimental validation of tumorigenic role of PPIA in gastric cancer. | Sci Rep | 2023 | 37926757 | PubTator, text mining | PubMed |
| A review on the role of gamma-butyrobetaine hydroxylase 1 antisense RNA 1 in the carcinogenesis and tumor progression. | Cancer Cell Int | 2023 | 37925403 | PubTator, text mining | PubMed |
| Small RNAs, spermatogenesis, and male infertility: a decade of retrospect. | Reprod Biol Endocrinol | 2023 | 37924131 | PubTator, text mining | PubMed |
| Exosomal circRNA RHOT1 promotes breast cancer progression by targeting miR-204-5p/ PRMT5 axis. | Cancer Cell Int | 2023 | 37924099 | PubTator, text mining | PubMed |
| Genetic and epigenetic factors of arterial hypertension: a bibliometric- and in-silico-based analyses. | Front Mol Biosci | 2023 | 37900914 | PubTator, text mining | PubMed |
| Validating Sam68 expression and protein level in breast cancer. | J Med Life | 2023 | 37900073 | PubTator, text mining | PubMed |
| Analysis of miRNAs in Osteogenesis imperfecta Caused by Mutations in COL1A1 and COL1A2: Insights into Molecular Mechanisms and Potential Therapeutic Targets. | Pharmaceuticals (Basel) | 2023 | 37895885 | PubTator, text mining | PubMed |
| Effects of Mithramycin on BCL11A Gene Expression and on the Interaction of the BCL11A Transcriptional Complex to γ-Globin Gene Promoter Sequences. | Genes (Basel) | 2023 | 37895276 | PubTator, text mining | PubMed |
| Prognostic Factors and Markers in Non-Small Cell Lung Cancer: Recent Progress and Future Challenges. | Genes (Basel) | 2023 | 37895255 | PubTator, text mining | PubMed |
| The Application of MicroRNAs in Glaucoma Research: A Bibliometric and Visualized Analysis. | Int J Mol Sci | 2023 | 37895056 | PubTator, text mining | PubMed |
| MicroRNAs in Prostate Cancer: Implications for Treatment Response and Therapeutic Targets. | Cancers (Basel) | 2023 | 37894390 | PubTator, text mining | PubMed |
| Therapeutic Potential of Cannabis: A Comprehensive Review of Current and Future Applications. | Biomedicines | 2023 | 37893004 | PubTator, text mining | PubMed |
| TRP Channels in Cancer: Signaling Mechanisms and Translational Approaches. | Biomolecules | 2023 | 37892239 | PubTator, text mining | PubMed |
| The Intergenic Type LncRNA (LINC RNA) Faces in Cancer with In Silico Scope and a Directed Lens to LINC00511: A Step toward ncRNA Precision. | Noncoding RNA | 2023 | 37888204 | PubTator, text mining | PubMed |
| Retracted: Mir-204 Regulates LPS-Induced A549 Cell Damage by Targeting FOXK2. | J Healthc Eng | 2023 | 37886320 | PubTator, text mining | PubMed |
| Molecular subtypes of epilepsy associated with post-surgical seizure recurrence. | Brain Commun | 2023 | 37881482 | PubTator, text mining | PubMed |
| MicroRNA‑mediated regulation in lung adenocarcinoma: Signaling pathways and potential therapeutic implications (Review). | Oncol Rep | 2023 | 37859595 | PubTator, text mining | PubMed |
| Relevance of micro-RNAs and their targets as a diagnostic and prognostic marker in oral squamous cell carcinoma. | J Oral Maxillofac Pathol | 2023 | 37854932 | PubTator, text mining | PubMed |
| The Role of microRNAs in Regulating Cancer Cell Response to Oxaliplatin-Containing Regimens. | Technol Cancer Res Treat | 2023 | 37849311 | PubTator, text mining | PubMed |
| Dysregulation of the circ_0087502/miR-1179/TGFBR2 pathway supports gemcitabine resistance in pancreatic cancer. | Cancer Biol Ther | 2023 | 37844011 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406987/papers?page=13